An anonymous director reports

CIPHER PHARMACEUTICALS SCHEDULES Q2 2023 EARNINGS RELEASE AND CONFERENCE CALL

Cipher Pharmaceuticals Inc. will release its financial results for the second quarter of 2023 on Thursday, Aug. 10, 2023. The company will also host a conference call on Friday, Aug. 11, 2023, at 8:30 a.m. ET, to discuss the results and corporate developments.

Conference call details

Date:  Friday, Aug. 11, 2023

Time:  8:30 a.m. ET

Dial-in number:   416-764-8650 or 888-664-6383

Conference ID:  40452017

Replay dial-in numbers:  888-390-0541 (playback 959756 followed by the number sign); expires Aug. 18, 2023

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early-stage to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America.